By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panelists agree that Brookfield's 15% annual plan value growth target is ambitious and relies on several execution risks, including fee-related earnings expansion, capital allocation discipline, and maintaining yields in infrastructure and renewables. They also highlight liquidity risks, particularly in private credit markets, which could derail the growth target.
Risk: Liquidity risks in private credit markets and potential mark-to-model gaps during a high-rate environment.
Opportunity: Sustainable growth of plan value by >15% annually, backed by diversified infrastructure, renewables, private assets, and an expanding insurance platform.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Brookfield Corporation focuses on plan value per share, its estimate of the long-term intrinsic value of its assets.
Management is aiming for annual intrinsic value growth of more than 15%.
Execution is the real driver.
Most investors focus on earnings or asset value when valuing a stock. Brookfield Corporation (NYSE: BN) wants you to focus on something else.
It tracks a metric called plan value per share, which is its estimate of the business's value based primarily on long-term cash flows. That metric doesn't necessarily move much in any single quarter, but over time, it can offer a better picture of how the company is really performing.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
The idea is simple: If Brookfield grows its plan value, its share price will follow that over time.
Brookfield's unique approach to valuing its stock reflects how it runs the business. Instead of managing for short-term results, it focuses on building long-duration cash flows across infrastructure, renewable energy, and private investments. It also continues to expand its insurance platform, which now manages more than $100 billion in assets.
All of these pieces feed into plan value per share. In simple terms, it's Brookfield's way of answering a straightforward question: What is the business worth if it continues to execute over time?
Brookfield has set a clear objective: Grow intrinsic value at more than 15% per year. More precisely, the company aims to grow its plan value from $68 to $140 from 2025 to 2030.
That's not just an aspirational number. Over the past five years, the company reports that its plan value per share has grown at roughly 16% annually (from $32 to $67). That track record matters. It suggests that the model has already worked, giving the company credibility for repeating that performance in the future.
In other words, Brookfield isn't just projecting something new; it's still doing what it has done before.
For Brookfield to achieve its goal, it has to continue executing at a high level. That means it needs to keep growing its fee-related earnings, continue allocating capital effectively, and manage its insurance business with discipline.
None of these is a simple task, especially with the ongoing changes in external environments. But these are also areas where the company has built experience over time, so the management team is not building castles in thin air.
Compounding does not always feel dramatic in the short term, but it becomes powerful over time. At a 15% annual growth rate, intrinsic value would roughly double in about five years.
That does not mean the stock will follow the same path quarter to quarter. Market prices can move unpredictably. But over longer periods, they tend to track the business's underlying performance.
For perspective, Brookfield Corporation's stock price has delivered a 19% annualized return over the past 30 years, suggesting that the business model is working.
If Brookfield continues to grow its plan value per share at a similar pace, it will be a matter of time before the stock price doubles from here.
Before you buy stock in Brookfield Corporation, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Brookfield Corporation wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $469,293! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,381,332!
Now, it’s worth noting Stock Advisor’s total average return is 993% — a market-crushing outperformance compared to 207% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of May 17, 2026. *
Lawrence Nga has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Brookfield Corporation. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"Brookfield's internal plan value growth target ignores material interest-rate and execution risks that could prevent the stock from tracking that trajectory."
The article frames Brookfield's plan value per share as a reliable compass for long-term compounding at 15%+, citing a $68 to $140 target by 2030 and 16% historical growth. Yet this metric is management's own estimate of discounted cash flows, not a market price or audited NAV. Renewables and infrastructure assets remain highly sensitive to interest rates and power prices, while the insurance platform's $100B+ AUM introduces credit and duration mismatch risks the piece barely acknowledges. Past 19% stock returns over 30 years occurred in a falling-rate tailwind that is unlikely to repeat.
Even if plan value compounds at 15%, BN shares could continue trading at a persistent discount to that figure, as they have for years, while management issues new equity to fund growth and dilutes existing holders.
"Plan value growth of 15% assumes a benign macro regime (lower rates, stable insurance underwriting, fee growth) that is not guaranteed, yet the article presents execution as the only variable that matters."
Brookfield's 15% annual plan value growth target hinges on three execution risks the article treats as solved: (1) fee-related earnings expansion in a crowded alternatives space where margins compress; (2) capital allocation discipline across 100+ billion in insurance assets—a sector facing underwriting headwinds and rising rates that compress float returns; (3) sustained infrastructure/renewable yield maintenance as cap rates normalize post-2021 lows. The 16% historical track record is real, but it occurred during a 13-year bull market in long-duration assets and falling discount rates. The article conflates past outperformance with future repeatability without stress-testing what happens if real rates stay elevated or insurance underwriting deteriorates.
If Brookfield executes flawlessly and real rates fall back toward 2% by 2028, the doubling thesis is plausible; the 30-year 19% CAGR is genuine proof of concept, not luck.
"Brookfield's 15% growth target is highly dependent on favorable credit conditions and aggressive capital deployment in their insurance arm, which remains opaque to public market investors."
Brookfield Corporation (BN) is essentially a compounding machine, but the 'plan value' metric is a management-defined internal valuation, not a GAAP standard. While their 15% growth target is impressive, it relies heavily on the continued expansion of their insurance platform—specifically the spread between investment returns and policy liabilities. The risk here isn't just execution; it's the sensitivity to interest rate volatility and the potential for a liquidity crunch in private credit markets. If the cost of capital stays higher for longer, the hurdle rate for new acquisitions rises, potentially compressing the margins that fuel that 15% intrinsic value growth. Investors are effectively buying a black box of alternative assets, trusting management's internal mark-to-model valuations over public market pricing.
The reliance on internal 'plan value' metrics masks potential mark-to-market losses in their private asset portfolio that could be revealed if they were forced to liquidate assets in a downturn.
"Brookfield's plan-value framework could deliver meaningful long-term upside if management sustains >15% annual intrinsic-value growth, but success hinges on plan value translating into real cash flow and not just a management benchmark in a higher-rate environment."
Brookfield's plan-value framework flips the usual earnings-and-book-value lens by prioritizing long-duration cash flows. If management sustainably grows plan value by >15% annually, the stock should compound as the market eventually discounts the business on compatible long-duration risk. The bullish takeaway is that Brookfield has a track record of roughly 16% plan-value growth over five years, backed by diversified infrastructure, renewables, private assets, and an expanding insurance platform. But the article glosses over crucial friction: plan value is internal and non-GAAP; it may diverge from realized cash and from peer valuations. In a higher-rate world or with asset-price cycles cooling, discount rates rise and plan-value growth could stall, pressuring the multiple.
Plan value is an internal metric; even a sustained 15% growth may not translate into near-term stock gains if rates rise, asset valuations cool, or Brookfield dilutes equity to fund growth.
"Liquidity risks in private credit could expose valuation gaps and halt plan value growth."
Claude flags insurance underwriting and rate sensitivity as key risks, but the bigger unmentioned threat is liquidity in their private credit book during a prolonged high-rate environment. If redemption pressures hit the insurance platform's $100B AUM, forced sales could reveal mark-to-model gaps that Gemini notes, derailing the 15% plan value growth regardless of fee margin trends. Historical compounding benefited from easy exits that may not recur.
"Insurance platform stress and private credit illiquidity are separate failure modes; conflating them obscures which actually threatens the 15% thesis."
Grok's liquidity stress scenario is real, but it conflates two separate risks. Insurance float redemptions and private credit illiquidity are distinct problems. Brookfield's insurance platform is liability-driven (premiums fund payouts), not redemption-gated like a fund. The actual pressure point is whether rising rates compress underwriting spreads faster than fee income grows—Claude's core concern. Private credit illiquidity matters only if Brookfield must liquidate to cover insurance payouts, which requires a severe underwriting loss or capital flight, not just mark-to-model divergence.
"Brookfield's reliance on capital recycling makes them highly vulnerable to private credit liquidity crunches, which would force them to hold illiquid assets and inflate their balance sheet risk."
Claude is right about the liability-driven nature of insurance, but both Claude and Grok miss the systemic risk of Brookfield's 'asset-light' fee-earning model. When private credit markets freeze, Brookfield’s ability to recycle capital via third-party funds stalls. This forces them to hold assets on their own balance sheet longer, ballooning their capital intensity and exposing them to the very mark-to-model risks Gemini flagged. It is not just about insurance payouts; it is about the entire capital recycling engine seizing up.
"Liquidity constraints in Brookfield's private-credit book and capital-recycling engine can derail plan-value growth even if underwriting margins stay intact."
I agree liquidity risk is underplayed, but let's connect the dots: Grok highlights private-credit illiquidity; Gemini expands to 'capital recycling stalls' when markets freeze. The combined effect is a feedback loop: higher rates dampen private asset realizations, slowing distributions to Brookfield's insurance float, which pressures capital redeployment and potentially forces equity issuance. That would suppress plan-value growth even if underwriting margins hold — a risk the article and some panelists treat as separate.
The panelists agree that Brookfield's 15% annual plan value growth target is ambitious and relies on several execution risks, including fee-related earnings expansion, capital allocation discipline, and maintaining yields in infrastructure and renewables. They also highlight liquidity risks, particularly in private credit markets, which could derail the growth target.
Sustainable growth of plan value by >15% annually, backed by diversified infrastructure, renewables, private assets, and an expanding insurance platform.
Liquidity risks in private credit markets and potential mark-to-model gaps during a high-rate environment.